CoChat

Delivery of Retinoid-Based Therapies To Target Tissues

Open access

The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.

Abstract

Through its various metabolites, vitamin A controls essential physiological functions. Both naturally occurring metabolites and novel retinoid analogues have shown effectiveness in many clinical settings that include skin diseases and cancer, and in animal models of human conditions affecting vision. In this review, we analyze several potential retinoid-based therapies from the point of view of drug metabolism and transport to target tissues. We focus on the endogenous factors that affect the absorption, transport, and metabolism of retinoids by taking into account data obtained from the analysis of animal models that lack the enzymes or proteins involved in the storage and absorption of retinoids. We also discuss findings of toxicity associated with retinoids in an effort to improve the outcome of retinoid-based therapies. In this context, we review evidence that esterification of retinol and retinol-based drugs within target tissues provides one of the most efficient means to improve the absorption and to reduce the toxicity associated with pharmacological doses of retinoids. Future retinoid-based therapeutic strategies could involve targeted delivery mechanisms leading to lower toxicity and improved effectiveness of retinoids.

Overview

Integrity signals

Registry

Crossref · 10.1021/bi7003069

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 138 references

Research works printed but not linked: 87

  1. Wald G., 1968, Science 162, 230−239.
  2. Mark M., 2006, Rev. Pharmacol. Toxicol., 46
  3. Heyman R. A., 1992, Cell 68, 397−406.
  4. Buck J., 1991, Science 254, 1654−1656.
  5. Derguini F., 1994, Biochemistry 33, 623−628.
  6. Humphrey J. H., 1992, Bull. W. H. O. 70, 225−232.
  7. Chomienne C., 1989, Lancet 2, 746−747.
  8. Hong W. K., 1997, Science 278, 1073−1077.
  9. Simeone A. M., 2004, Cell. Mol. Life Sci. 61, 1475−1484.
  10. Hail N., Jr., 2006, Apoptosis 11, 1677−1694.
  11. Travis G. H., 2007, Rev. Pharmacol. Toxicol., 47
  12. Van Hooser J. P., 2000, Proc. Natl. Acad. Sci. U.S.A. 97
  13. Maeda A., 2006, Invest. Ophthalmol. Visual Sci. 47, 4540−4546.
  14. Golczak M., 2005, Proc. Natl. Acad. Sci. U.S.A. 102
  15. Radu R. A., 2004, Novartis Found. Symp. 255
  16. Radu R. A., 2005, Invest. Ophthalmol. Visual Sci. 46, 4393−4401.
  17. van Bennekum A. M., 2000, Biochemistry 39, 4900−4906.
  18. Rigtrup K. M., 1994, Biochemistry 33, 2661−2666.
  19. Harrison E. H., 2005, Rev. Nutr., 25, 103
  20. Tso P., 2001, J. Nutr., 131
  21. MacDonald P. N., 1988, Biochem. Biophys. Res. Commun. 156, 157−163.
  22. MacDonald P. N., 1988, J. Biol. Chem., 263
  23. Herr F. M., 1992, Biochemistry 31, 6748−6755.
  24. Ong D. E., 1994, Nutr. Rev., 52
  25. Randolph R. K., 1991, Arch. Biochem. Biophys. 288, 500−508.
  26. Otarod J. K., 2004, Curr. Atheroscler. Rep. 6, 335−342.
  27. Vogel S., 2002, Biochemistry 41, 15360−15368.
  28. Quadro L., 2005, Endocrinology 146, 4479−4490.
  29. Blomhoff R., 1985, J. Biol. Chem., 260
  30. Peterson P. A., 1971, J. Biol. Chem., 246, 49
  31. Melhus H., 1991, Exp. Cell Res. 197, 119−124.
  32. Vogel S., 1999, The Handbook of Experimental Pharmacology: Retinoids: The Biochemical and Molecular Basis of Vitamin A and Retinoid Action, 139
  33. Noy N., 1990, Biochemistry 29, 3883−3888.
  34. Noy N., 2000, Biochem. J., 348
  35. Noy N., 1991, Biochemistry 30, 6380−6386.
  36. Heller J., 1975, J. Biol. Chem., 250
  37. International Agency for Research on Cancer., 2000, IARC Handbooks of Cancer Prevention, 4
  38. Sundaram M., 1998, J. Biol. Chem., 273
  39. Kawaguchi R., 2007, Science 315, 820−825.
  40. Bouillet P., 1995, Stra1 (mouse LERK-2/Eplg2), Dev. Biol. 170, 420−433.
  41. Bouillet P., 1997, Mech. Dev. 63, 173−186.
  42. Seeliger M. W., 1999, Invest. Ophthalmol. Visual Sci., 40, 11
  43. Blaner W. S., 2007, Cell Metab. 5, 164−166.
  44. Noy N., 1992, Biochemistry 31, 11118−11124.
  45. Retinoic Acid, 2000, IARC Handbooks of Cancer Prevention, 4
  46. Krasinski S. D., 1990, Metabolism 39, 357−365.
  47. Liu L., 2005, J. Biol. Chem., 280
  48. Wei S., 1997, J. Biol. Chem., 272
  49. Yen C. L., 2005, J. Lipid Res., 46
  50. Orland M. D., 2005, Biochim. Biophys. Acta, 1737, 82
  51. Isken A., 2006, J. Biol. Chem., 282
  52. Zile M. H., 1980, Proc. Natl. Acad. Sci. U.S.A. 77
  53. Frolik C. A., 1981, Arch. Biochem. Biophys. 208, 344−352.
  54. Napoli J. L., 1982, Biochemistry 21
  55. Zhang L., 2002, J. Biol. Chem., 277
  56. Vogel S., 2001, J. Biol. Chem., 276
  57. Ross A. C., 2006, J. Lipid Res., 47
  58. Ross A. C., 2006, J. Nutr., 136
  59. Mangelsdorf D. J., 1991, Cell 66, 555−561.
  60. Tang X. H., 2007, J. Lipid Res., 48
  61. Guo X., 2000, Carcinogenesis 21
  62. Guo X., 2001, Cancer Res. 61, 2774−2781.
  63. Guo X., 2002, Cancer Res. 62, 1654−1661.
  64. Simmons D. P., 2002, Carcinogenesis 23
  65. Zhan H. C., 2003, Clin. Cancer Res. 9, 4897−4905.
  66. Boorjian S., 2004, Clin. Cancer Res. 10, 3429−3437.
  67. Sheren-Manoff M., 2006, Int. J. Oncol., 29
  68. Lotan R., 1980, J. Natl. Cancer Inst., 64
  69. Fex G., 1986, Br. J. Cancer, 53
  70. Fex G., 1986, Int. J. Cancer, 37
  71. Fex G., 1985, Breast Cancer Res. Treat. 6, 131−136.
  72. Kuppumbatti Y. S., 2001, Oncogene 20, 7413−7419.
  73. Soprano D. R., 1995, Rev. Nutr., 15
  74. Collins M. D., 1999, Rev. Pharmacol. Toxicol., 39
  75. Cohlan S. Q., 1953, Science 117, 535−536.
  76. Cohlan S. Q., 1954, Pediatrics 13, 556−567.
  77. Geelen J. A., 1980, Anat. Embryol. 159, 223−234.
  78. Collins M. D., 1994, Toxicol. Appl. Pharmacol. 127, 132−144.
  79. Berson E. L., 1993, Arch. Ophthalmol. 111, 761−772.
  80. Guarascio P., 1983, J. Clin. Pathol., 36
  81. Nollevaux M. C., 2006, Liver Int. 26, 182−186.
  82. Hautekeete M. L., 1997, Virchows Arch. 430, 195−207.
  83. Baxi S. C., 1982, West. J. Med., 137
  84. Genaro Pde S., 2004, Nutr. Rev., 62, 7
  85. Melhus H., 1998, 129, 770−778.
  86. Maeda A., 2006, Mol. Pharmacol. 70, 1220−1229.
  87. Abbreviations E, pyridinium bis-retinoid

Cited by

See all 116

Metadata

Authors
Moise, A. R., Noy, N., Palczewski, K., & Blaner, W. S.
Affiliations
Case Western Reserve University (US)
Venue
Biochemistry
Published
2007-03-23
Volume
46
Issue
15
Pages
4449-4458
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W2107673143
Cited by
93
References
138
Citations by year
2026: 1 · 2024: 6 · 2023: 5 · 2022: 2 · 2021: 10 · 2020: 4 · 2019: 4 · 2018: 4 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 2 · 2013: 4 · 2012: 7
FWCI
0.56
Type
journal article
Language
en
Open access
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Eye Institute (EY-01730, R01EY008061, EY 08061, R03EY015399, EY015399, P30EY001730)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK068437, DK 068437, R56DK068437)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Keywords
retinoids, vitamin A, vitamin A metabolism, retinoid transport, retinol esterification, retinoid toxicity, retinoid analogues, targeted drug delivery, skin diseases, cancer therapy, visual disturbances
MeSH terms
Animals, Humans, Intestinal Absorption, Models, Biological, Retinoids, Retinol-Binding Proteins, Tissue Distribution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.